Tetracycline Articles
Patent suit filed in USA over Doryx generic
12 January 2009
India's OTC drug market boom
23 April 2007
Wyeth's Tygacil cleared in European Union
15 May 2006
Merck & Co gets Paratek's antibiotic in $127M deal
20 March 2006
Serono and Paratek sign MS accord
1 November 2004
Chinese pharma hit by price cuts on antibiotics
30 August 2004
Warner Chilcott beats expectations
16 August 2004
India acts on prices of 87 drug formulations
9 June 2003
Galen's profits grow as sales rocket 57%
19 May 2003
China fast-tracks SARS Rx approvals, imports
12 May 2003
Axcan's Helicide approved in Canada
31 March 2003
Galen EPS leaps 35%, beating forecasts
17 February 2003
FDA rejects Axcan's Helicide for H pylori
19 August 2002
Axcan to acquire France's Lacteol
15 April 2002
UK nurse Rxers' list widens to antibiotics
25 February 2002
India's NPPA revises 81 formulation prices
14 January 2002
Axcan files for approval of Helicide in USA and Canada
5 October 2001
CollaGenex starts Ph II Kaposi's sarcoma trial
6 August 2001
EU's wide variety of antibiotic sales: study
13 June 2001
Indian essential drugs' price curbs "must stay"
21 May 2001
Analysts expectant on future prospects for Canada's Axcan Pharma
13 February 2001
India's drug pricing authority to be probed
3 October 2000
Paratek completes $20 million financing
27 June 2000
India revises the prices of 16 drug products
30 September 1999
Glaxo Wellcome and Paratek link up
30 July 1999
India moves on bulk drug output, excise
8 February 1999
Canadian antibiotic Rxing "down 10%"
26 January 1999
New Antibacterials Showcased At ICAAC
14 October 1998
First Oral Periodontitis Treatment In USA
8 October 1998
Oncology Update In Brief
8 December 1997
BMA Reveals New Guidelines For Antibiotics
6 November 1997
Will New Wave Of Antibiotics Fight Resistance?
23 October 1997
US H2 Blocker Boom Forecast To Slow Down
27 January 1997
13 Indian Pharma Firms Charged By Customs
25 November 1996
Bradley Pharma Settles Patent Dispute With P&G
4 November 1996
P&G To Launch Low-Cost Helicobacter Regimen In USA
2 September 1996
BASF Acquires Drug Discovery Tool
20 May 1996
Ulcer Therapy Market Set For Transformation
18 December 1995
China: Fermentation, Antibiotics And The Need To Modernize
27 November 1995
UK Code Of Practice Amendments, New Report
25 September 1995
P & G NDA for bismuth....
7 August 1995
India Ends Bulk Drug Industrial Licensing
14 November 1994
Eradication Therapy For Helicobacter Pylori
10 October 1994
FIRST CLINICAL DATA FOR GLAXO'S GR122311X
6 June 1994
ACTISITE CLEARED FOR MARKET IN USA
11 April 1994
FUTURE LOOKS ROSY FOR LOSEC H PYLORI COMBO
4 April 1994
ROBERTS PHARMA SETS UP IN FRANCE
14 March 1994
NIH ISSUES CONSENSUS STATEMENT ON H PYLORI
14 February 1994
ZITHROMAX SIMPLIFIES TRACHOMA CONTROL
6 September 1993
NEW US OTC REGS WARN AGAINST MIXING DRUGS
6 September 1993
NEW DATA ON LOSEC IN ULCER RELAPSE
12 April 1993
UK PHARMA OUTPUT IN THIRD QTR 1992
8 February 1993
ALZA is STILL A STRONG BUY
14 December 1992
RPSGB CANDIDATES FOR POM-TO-P SWITCHING
2 November 1992
ZITHROMAX AND CHLAMYDIA
5 October 1992
WELLCOME CONFIRMATION
7 September 1992
H PYLORI TREATMENT: A ROLE FOR OMEPRAZOLE?
25 May 1992
STUDY SUPPORTS ULCER/H PYLORI HYPOTHESIS
11 May 1992
PHARMA ECONOMICS 1942/1992 PERSPECTIVE
23 March 1992
ROBERTS ACQUIRES TWO UPJOHN OTCs
13 January 1992
Showing 1-65 of 65 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
